NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/08/2026
Voltar para busca
Dado oficial do USPTO
ACTOLOG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
16/10/2019
Data de registro
26/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/01/2021
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
CALLOWAY, CHRISTINA DENISE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Immatics Biotechnologies GmbH
Representantes
Anna Kurian Shaw Hogan Lovells US LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical and pharmaceutical productsoncologicalanti-viralanti-bacterial and autoimmunity pharmaceuticals and natural remedies; diagnostic reagents for medical purposes; synthetic peptidesbinding proteins and living cells for medicaldiagnostic and therapeutic purposesin particular for cancer therapy
Classe 42
Medical research and pharmacological researchpharmaceutical research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistrybiochemistry and biology; scientific laboratory servicesbiologicalbiochemical and chemical laboratory services; biologicalbiochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory servicesbiological and biochemical laboratory services; biological and biochemical examination services of specimens in the field of cancer treatment and diagnosis
Classe 44
Medical servicesmedical and pharmacological diagnosis of oncologicalviralbacterialautoimmune diseases and pharmaceutical servicespharmaceutical compounding services for diagnosis and treatment of oncologicalviralbacterialautoimmune diseases; dispensing of pharmaceuticalsproviding medical supply for therapyin particular supply of synthetic peptidesbinding proteins and living cells for cancer therapy; medical diagnosis of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/04/2021
FIMP
FINAL DISPOSITION PROCESSED
29/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
26/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/12/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2020
PUBO
PUBLISHED FOR OPPOSITION
10/11/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/05/2020
RFNT
REFUSAL PROCESSED BY IB
21/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/03/2020
RFRR
REFUSAL PROCESSED BY MPU
02/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/02/2020
CNRT
NON-FINAL ACTION WRITTEN
26/02/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
25/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/01/2020
CNRT
NON-FINAL ACTION WRITTEN
30/01/2020
DOCK
ASSIGNED TO EXAMINER
22/01/2020
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACTOLOG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.